Page last updated: 2024-08-26

mci 9038 and Brain Ischemia

mci 9038 has been researched along with Brain Ischemia in 29 studies

Research

Studies (29)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (10.34)18.2507
2000's8 (27.59)29.6817
2010's11 (37.93)24.3611
2020's7 (24.14)2.80

Authors

AuthorsStudies
Du, Y; He, L; Liu, Q; Wang, H; Wang, J; Xu, J; Xu, X1
Anderson, M; Chuck, C; Feler, J; Jayaraman, MV; McTaggart, R; Moldovan, K; Poggi, J; Sweeney, J; Torabi, R1
Alwis, I; Hofma, BR; Jackson, SP; Maclean, JAA; Samson, AL; Schoenwaelder, SM; Sturgeon, SA; Tomkins, AJ1
Chen, HS; Cui, Y; Dai, YJ; Duan, YJ; Feng, YF; Jiang, CH; Li, GH; Liu, XD; Ma, GB; Peng, ZL; Shen, L; Sun, YL; Wang, DL; Wang, EQ; Wang, FY; Wang, K; Wang, LH; Wang, RX; Wang, YL; Yang, HP; Yang, QC; Yuan, ZM; Zhang, Y; Zhao, LW; Zhou, ZH; Zou, RL1
Wu, T; Xu, S; Xu, Z; Zhang, W; Zhang, Y1
Liu, P; Liu, S; Lu, H; Ma, X; Wang, L; Wang, P; Wang, Y; Zhang, F1
Cai, D; Chen, S; He, J; Huang, P; Lai, Y; Liu, J; Sun, H; Zhou, L1
Barreto, AD; Cai, C; Ford, GA; Grotta, JC; Pedroza, C; Rahbar, MH; Shen, L; Tyson, J1
Barreto, AD; Grotta, JC1
Shah, NH1
Abe, S; Mitaki, S; Oguro, H; Onoda, K; Takayoshi, H; Yamaguchi, S1
Ashida, S; Kojima, Y; Maezono, K; Nagakane, Y; Ogura, S; Tanaka, E; Yamamoto, Y1
Cao, S; Chen, L; Yang, J1
Chen, B; Lamb, J; Lei, IF; Lyden, P; Pereira, B; Rajput, P; Zhao, L1
Cervera, A; Chamorro, Á; de la Rosa, X; Durduran, T; Justicia, C; Kristoffersen, AK; Planas, AM; Valdés, CP; Varma, HM1
Alexandrov, AV; Balucani, C; Barlinn, K; Barreto, AD; Chen, Z; Demchuk, AM; Garami, Z; Gonzales, NR; Grotta, JC; Lee, J; Lyden, P; Martin-Schild, S; Mikulik, R; Pandurengan, R; Rahbar, MH; Savitz, SI; Shen, L; Sisson, A; Sugg, RM; Tsivgoulis, G; Wu, TC1
Kumagai, N; Nagao, T; Okuhara, Y; Origasa, H; Takekawa, H; Yamaguchi, T1
Alexandrov, AV; Bavarsad Shahripour, R1
LaMonte, MP1
Aoki, T; Matsuoka, N; Mihara, K; Moriguchi, A; Mutoh, S; Tojo, N1
LaMonte, MP; Stallmeyer, MJ1
Brown, PM; Hursting, MJ; LaMonte, MP1
Nishimura, S; Nishino, A; Numagami, Y; Sakurai, Y; Suzuki, H; Suzuki, I; Suzuki, S; Uenohara, H; Utsunomiya, A1
Haines, ST; Hursting, MJ; LaMonte, MP; Mikdashi, JA; Patterson, SL1
Kario, K; Kodama, K; Koide, M; Matsuo, T1
Kawai, H; Sugimoto, J; Tamao, Y; Yuki, S1
Akiguchi, I; Tomimoto, H1
Berens, KL; Brown, PM; Chopp, M; Lu, M; Morris, DC; Zhang, L; Zhang, ZG1
Jin, YJ; Mima, T; Park, KC; Raicu, V; Shimizu, K1

Reviews

6 review(s) available for mci 9038 and Brain Ischemia

ArticleYear
Ancillary approaches to plasminogen activators.
    Annals of the New York Academy of Sciences, 2012, Volume: 1268

    Topics: Anticoagulants; Arginine; Brain Ischemia; Cerebral Hemorrhage; Clinical Trials as Topic; Collateral Circulation; Drug Synergism; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Hypothermia, Induced; Low-Level Light Therapy; Pipecolic Acids; Plasminogen Activators; Platelet Aggregation Inhibitors; Prospective Studies; Recombinant Proteins; Sulfonamides; Thrombolytic Therapy; Tirofiban; Tyrosine; Ultrasonic Therapy; Vasodilator Agents

2012
Argatroban in thrombotic stroke.
    Pathophysiology of haemostasis and thrombosis, 2002, Volume: 32 Suppl 3

    Topics: Animals; Anticoagulants; Arginine; Brain Ischemia; Collateral Circulation; Humans; Pipecolic Acids; Stroke; Sulfonamides; Thrombin; Thrombosis

2002
Alternative parenteral anticoagulation with argatroban, a direct thrombin inhibitor.
    Expert review of cardiovascular therapy, 2005, Volume: 3, Issue:1

    Topics: Anticoagulants; Arginine; Brain Ischemia; Clinical Trials as Topic; Dose-Response Relationship, Drug; Heparin; Humans; Pipecolic Acids; Platelet Aggregation Inhibitors; Risk Factors; Sulfonamides; Thrombin; Thrombocytopenia

2005
[Nontraumatic arterial dissection of the anterior cerebral artery: six cases report].
    No to shinkei = Brain and nerve, 2005, Volume: 57, Issue:6

    Topics: Adult; Aged; Anterior Cerebral Artery; Anticoagulants; Aortic Dissection; Arginine; Brain Ischemia; Cerebral Angiography; Female; Humans; Hypertension; Infarction, Anterior Cerebral Artery; Intracranial Aneurysm; Magnetic Resonance Imaging; Male; Middle Aged; Pipecolic Acids; Prognosis; Subarachnoid Hemorrhage; Sulfonamides

2005
Anticoagulation strategies for treatment of ischemic stroke and antiphospholipid syndrome: case report and review of the literature.
    Pharmacotherapy, 2006, Volume: 26, Issue:10

    Topics: Anticoagulants; Antiphospholipid Syndrome; Arginine; Azathioprine; Brain Ischemia; Dexamethasone; Humans; Male; Middle Aged; Pipecolic Acids; Stroke; Sulfonamides; Warfarin

2006
[The role of immunologic reactions in the pathogenesis in Binswanger's disease; a clue to therapeutic approach].
    Rinsho shinkeigaku = Clinical neurology, 1999, Volume: 39, Issue:1

    Topics: Animals; Antithrombins; Arginine; Blood Coagulation Factors; Brain; Brain Ischemia; Cyclosporine; Dementia, Vascular; Humans; Immunosuppressive Agents; Neuroglia; Pipecolic Acids; Sulfonamides; Thrombin

1999

Trials

5 trial(s) available for mci 9038 and Brain Ischemia

ArticleYear
Effect of Argatroban Plus Intravenous Alteplase vs Intravenous Alteplase Alone on Neurologic Function in Patients With Acute Ischemic Stroke: The ARAIS Randomized Clinical Trial.
    JAMA, 2023, 02-28, Volume: 329, Issue:8

    Topics: Aged; Brain Ischemia; Female; Fibrinolytic Agents; Humans; Ischemic Stroke; Male; Stroke; Tissue Plasminogen Activator; Treatment Outcome

2023
Argatroban Increased the Basal Vein Drainage and Improved Outcomes in Acute Paraventricular Ischemic Stroke Patients.
    Medical science monitor : international medical journal of experimental and clinical research, 2020, Jul-15, Volume: 26

    Topics: Aged; Antithrombins; Arginine; Blood Flow Velocity; Brain Ischemia; Cerebral Veins; Drainage; Drug Therapy, Combination; Female; Humans; Ischemic Stroke; Male; Middle Aged; Pipecolic Acids; Sulfonamides; Tissue Plasminogen Activator

2020
Randomized, Multicenter Trial of ARTSS-2 (Argatroban With Recombinant Tissue Plasminogen Activator for Acute Stroke).
    Stroke, 2017, Volume: 48, Issue:6

    Topics: Aged; Aged, 80 and over; Antithrombins; Arginine; Brain Ischemia; Cerebral Hemorrhage; Drug Therapy, Combination; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Pipecolic Acids; Severity of Illness Index; Stroke; Sulfonamides; Tissue Plasminogen Activator

2017
Prognostic significance of smoking in patients with acute ischemic stroke within 3 months of onset.
    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2013, Volume: 22, Issue:6

    Topics: Aged; Aged, 80 and over; Antipyrine; Arginine; Brain Ischemia; Chi-Square Distribution; Disability Evaluation; Drug Therapy, Combination; Edaravone; Female; Fibrinolytic Agents; Humans; Japan; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Pipecolic Acids; Recovery of Function; Risk Factors; Smoking; Smoking Cessation; Smoking Prevention; Stroke; Sulfonamides; Time Factors; Treatment Outcome

2013
Thrombin inhibition in the acute phase of ischaemic stroke using argatroban.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 1995, Volume: 6, Issue:5

    Topics: Aged; Antithrombins; Arginine; Brain Ischemia; Double-Blind Method; Female; Fibrin Fibrinogen Degradation Products; Glycerol; Humans; Male; Middle Aged; Partial Thromboplastin Time; Pipecolic Acids; Placebos; Reference Values; Sulfonamides; Thrombin; Thromboplastin

1995

Other Studies

18 other study(ies) available for mci 9038 and Brain Ischemia

ArticleYear
Dual Antiplatelet Therapy Plus Argatroban Prevents Early Neurological Deterioration in Branch Atherosclerosis Disease.
    Stroke, 2022, Volume: 53, Issue:1

    Topics: Arginine; Aspirin; Atherosclerosis; Brain Ischemia; Clopidogrel; Humans; Pipecolic Acids; Platelet Aggregation Inhibitors; Stroke; Sulfonamides; Ticlopidine

2022
Dual antiplatelet use in the management of COVID-19 associated acute ischemic stroke reocclusion.
    Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences, 2023, Volume: 29, Issue:5

    Topics: Aspirin; Brain Ischemia; COVID-19; Humans; Ischemic Stroke; Middle Aged; Retrospective Studies; SARS-CoV-2; Stroke; Thrombectomy; Ticagrelor; Treatment Outcome

2023
Development of a carotid artery thrombolysis stroke model in mice.
    Blood advances, 2022, 09-27, Volume: 6, Issue:18

    Topics: Animals; Anticoagulants; Antithrombins; Arginine; Brain Ischemia; Carotid Artery, Common; Fibrinolytic Agents; Infarction, Middle Cerebral Artery; Ischemic Stroke; Mice; Pipecolic Acids; Stroke; Sulfonamides; Thromboembolism; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome

2022
Efficacy and Prognosis of Adjuvant Argatroban Treatment in Acute Ischemic Stroke Patients with Early Neurological Deterioration.
    Discovery medicine, 2023, 04-01, Volume: 35, Issue:175

    Topics: Aspirin; Brain Ischemia; Humans; Ischemic Stroke; Prognosis; Stroke; Treatment Outcome

2023
Early and long-term outcomes of argatroban use in patients with acute noncardioembolic stroke.
    Clinical neurology and neurosurgery, 2020, Volume: 198

    Topics: Aged; Arginine; Brain Ischemia; Endovascular Procedures; Female; Humans; Male; Middle Aged; Pipecolic Acids; Platelet Aggregation Inhibitors; Retrospective Studies; Stroke; Sulfonamides; Treatment Outcome

2020
Response by Barreto and Grotta to Letter Regarding Article, "Randomized, Multicenter Trial of ARTSS-2 (Argatroban With Recombinant Tissue Plasminogen Activator for Acute Stroke)".
    Stroke, 2017, Volume: 48, Issue:9

    Topics: Arginine; Brain Ischemia; Fibrinolytic Agents; Humans; Pipecolic Acids; Recombinant Proteins; Stroke; Sulfonamides; Tissue Plasminogen Activator; Treatment Outcome

2017
Letter by Shah Regarding Article, "Randomized, Multicenter Trial of ARTSS-2 (Argatroban With Recombinant Tissue Plasminogen Activator for Acute Stroke)".
    Stroke, 2017, Volume: 48, Issue:9

    Topics: Arginine; Brain Ischemia; Fibrinolytic Agents; Humans; Pipecolic Acids; Recombinant Proteins; Stroke; Sulfonamides; Tissue Plasminogen Activator; Treatment Outcome

2017
Retrospective Analysis of Argatroban in 353 Patients with Acute Noncardioembolic Stroke.
    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2018, Volume: 27, Issue:8

    Topics: Aged; Aged, 80 and over; Antithrombins; Arginine; Brain Ischemia; Female; Fibrinolytic Agents; Humans; Male; Methacrylates; Middle Aged; Pipecolic Acids; Prognosis; Retrospective Studies; Severity of Illness Index; Stroke; Sulfonamides

2018
[Safety of Dual Antiplatelet Therapy with Argatroban in Patients with Acute Ischemic Stroke].
    Brain and nerve = Shinkei kenkyu no shinpo, 2018, Volume: 70, Issue:5

    Topics: Arginine; Brain Ischemia; Drug Therapy, Combination; Humans; Ischemic Attack, Transient; Pipecolic Acids; Platelet Aggregation Inhibitors; Retrospective Studies; Stroke; Sulfonamides

2018
Argatroban plus aspirin versus aspirin in acute ischemic stroke.
    Neurological research, 2018, Volume: 40, Issue:10

    Topics: Arginine; Aspirin; Brain Ischemia; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Male; Pipecolic Acids; Platelet Aggregation Inhibitors; Retrospective Studies; Severity of Illness Index; Statistics as Topic; Stroke; Sulfonamides; Treatment Outcome

2018
Direct thrombin inhibitor argatroban reduces stroke damage in 2 different models.
    Stroke, 2014, Volume: 45, Issue:3

    Topics: Animals; Arginine; Brain; Brain Ischemia; Learning Curve; Male; Maze Learning; Pipecolic Acids; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Stroke; Sulfonamides; Thrombin

2014
Mannose-binding lectin promotes local microvascular thrombosis after transient brain ischemia in mice.
    Stroke, 2014, Volume: 45, Issue:5

    Topics: Animals; Antithrombins; Arginine; Brain Ischemia; Cerebrovascular Circulation; Disease Models, Animal; Fibrinogen; Infarction, Middle Cerebral Artery; Magnetic Resonance Imaging; Male; Mannose-Binding Lectin; Mice; Mice, Inbred C57BL; Mice, Knockout; Microcirculation; Pipecolic Acids; Reperfusion Injury; Sulfonamides; Thrombosis

2014
The argatroban and tissue-type plasminogen activator stroke study: final results of a pilot safety study.
    Stroke, 2012, Volume: 43, Issue:3

    Topics: Aged; Anticoagulants; Antithrombins; Arginine; Brain Ischemia; Cerebral Arteries; Cerebral Hemorrhage; Cerebral Veins; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Partial Thromboplastin Time; Pilot Projects; Pipecolic Acids; Stroke; Sulfonamides; Tissue Plasminogen Activator; Treatment Outcome; Ultrasonography, Doppler, Transcranial

2012
Antithrombotic effects of FK419, a novel nonpeptide platelet GPIIb/IIIa antagonist, in a guinea pig photochemically induced middle cerebral artery thrombosis model: comparison with ozagrel and argatroban.
    The Journal of pharmacology and experimental therapeutics, 2004, Volume: 308, Issue:3

    Topics: Animals; Antithrombins; Arginine; Blood Coagulation; Blood Platelets; Brain Ischemia; Disease Models, Animal; Guinea Pigs; Infarction, Middle Cerebral Artery; Male; Methacrylates; Pipecolic Acids; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Reperfusion Injury; Sulfonamides; Thromboxane B2

2004
Acute ischemic stroke successfully treated using sequenced intravenous and intra-arterial thrombolysis and argatroban anticoagulation: a case study.
    Journal of thrombosis and thrombolysis, 2004, Volume: 17, Issue:2

    Topics: Acute Disease; Adult; Anticoagulants; Arginine; Brain Ischemia; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Male; Pipecolic Acids; Stroke; Sulfonamides

2004
Effects of a thrombin inhibitor, argatroban, on ischemic brain damage in the rat distal middle cerebral artery occlusion model.
    The Journal of pharmacology and experimental therapeutics, 1996, Volume: 278, Issue:2

    Topics: Animals; Antithrombins; Arginine; Brain Ischemia; Cerebral Arteries; Disease Models, Animal; Male; Pipecolic Acids; Rats; Rats, Sprague-Dawley; Sulfonamides

1996
Extension of the therapeutic window for recombinant tissue plasminogen activator with argatroban in a rat model of embolic stroke.
    Stroke, 2001, Volume: 32, Issue:11

    Topics: Animals; Antithrombins; Arginine; Brain Ischemia; Cerebral Hemorrhage; Dose-Response Relationship, Drug; Fibrin; Incidence; Infarction, Middle Cerebral Artery; Intracranial Embolism; Male; Pipecolic Acids; Rats; Rats, Wistar; Recombinant Proteins; Stroke; Sulfonamides; Time Factors; Tissue Plasminogen Activator

2001
Combined argatroban and edaravone caused additive neuroprotection against 15 min of forebrain ischemia in gerbils.
    Neuroscience research, 2002, Volume: 43, Issue:1

    Topics: Animals; Anticoagulants; Antipyrine; Arginine; Body Water; Brain Edema; Brain Ischemia; Cerebral Infarction; Cerebrovascular Circulation; Drug Interactions; Drug Therapy, Combination; Edaravone; Endothelium, Vascular; Free Radical Scavengers; Free Radicals; Gerbillinae; Male; Nerve Degeneration; Neuroprotective Agents; Pipecolic Acids; Prosencephalon; Reperfusion Injury; Sulfonamides

2002